Arcutis Biotherapeutics, Inc. (ARQT)

Price & Market Data

Price: $20.50

Daily Change: -$0.74 / 3.61%

Daily Range: $20.27 - $21.56

Market Cap: $2,587,975,168

Daily Volume: 2,313,851

Performance Metrics

1 Week: -11.66%

1 Month: -14.22%

3 Months: -23.03%

6 Months: -14.61%

1 Year: 43.78%

YTD: -28.75%

About Arcutis Biotherapeutics, Inc. (ARQT)

Understand the current valuation of Arcutis Biotherapeutics, Inc. (ARQT). Trading at 20.50, the stock has observed a daily change of -$0.74 / 3.61%. A robust market capitalization of 2,587,975,168 underscores its market presence. Key performance indicators include YTD (-28.75%) and 1-year (43.78%) returns.

Company Details

Employees: 354

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Selected stocks

Ambarella, Inc. (AMBA)

Sunstone Hotel Investors, Inc. (SHO)

Arrow Electronics, Inc. (ARW)

iHeartMedia, Inc. (IHRT)

Capital Bancorp, Inc. (CBNK)